Related Experiment Videos
Modular structure of PACT: distinct domains for binding and activating PKR.
G A Peters1, R Hartmann, J Qin
1Department of Molecular Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Molecular and Cellular Biology
|March 10, 2001
Summary
The protein activator of PKR (PACT) protein has a modular structure. Domain 3 activates protein kinase R (PKR), while domains 1 and 2 bind PKR, enabling PACT to induce apoptosis and translation inhibition.
Area of Science:
- Molecular Biology
- Cellular Biology
- Protein Biochemistry
Background:
- PACT is a human protein that binds and activates protein kinase R (PKR).
- PKR activation by PACT leads to cellular apoptosis and translation inhibition.
- Understanding PACT's structure-function relationship is crucial for elucidating its biological roles.
Purpose of the Study:
- To analyze the structure-function relationship of PACT in binding and activating PKR.
- To identify specific domains within PACT responsible for PKR interaction and activation.
- To investigate the modularity of PACT's structure.
Main Methods:
- In vitro and in vivo assays to measure PACT's ability to bind and activate PKR.
- Structure-function analysis of PACT domains.
- Fusion protein experiments involving PACT domain 3 and maltose-binding protein.
Main Results:
- Domains 1 and 2 of PACT are sufficient for high-affinity binding to PKR.
- Domain 3 is essential for PKR activation both in vitro and in vivo.
- Domain 3 alone can activate PKR in vitro but shows poor binding and activation in vivo without a heterologous binding domain.
Conclusions:
- PACT possesses a modular structure with distinct PKR-interacting and PKR-activation domains.
- Domains 1 and 2 act as redundant PKR-binding domains.
- Domain 3 functions as the primary PKR-activation domain, requiring appropriate PKR interaction for in vivo efficacy.